DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and ther...
Saved in:
| Main Authors: | L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-08-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/1307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
by: L. V. Cherenova, et al.
Published: (2017-05-01) -
Developing the next-generation of adenoviral vector vaccines
by: Alexander T. Sampson, et al.
Published: (2025-12-01) -
Bovine Adenoviral Vector-Based Platform for Vaccine Development
by: Ekramy E. Sayedahmed, et al.
Published: (2025-05-01) -
A Case Report of Adenoviral Pneumonia with Splenic Infarction
by: Gajam Siddhartha, et al.
Published: (2024-11-01) -
Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
by: Xi Yang, et al.
Published: (2019-01-01)